A 16-page draft of a white paper on the need for Federal government support of high-risk high-reward technologies platforms tools in non-invasively monitoring proteins in living tissues and systems in real time, data integration and analysis, and more effective biopharmaceutical manufacturing for personalized medicine.
| Date Of Record Release | 2011-03-25 16:40:42 |
|---|---|
| Description | A 16-page draft of a white paper on the need for Federal government support of high-risk high-reward technologies platforms tools in non-invasively monitoring proteins in living tissues and systems in real time, data integration and analysis, and more effective biopharmaceutical manufacturing for personalized medicine. |
| Classification | |
| Resource Type | |
| Format | |
| Subject | |
| Source | National Institute of Standards and Technology |
| Keyword | Healthcare, Investment, High-risk technology, Biopharamaceutical manufacturing, Pharamaceutical development, Clinical trial, Diagnostic efficiency, Biofuels, Biodetergents, Plastics, Agricultural products |
| Selector | Selection Committee |
| Date Of Record Creation | 2011-03-25 16:25:32 |
| Education Level | |
| Date Last Modified | 2011-03-30 18:08:40 |
| Language | English |
1999–2013 Advanced Technology Environmental and Energy Center | Leave Feedback
Create a Login